Correlation Between Mymetics Corp and Statera Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mymetics Corp and Statera Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mymetics Corp and Statera Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mymetics Corp and Statera Biopharma, you can compare the effects of market volatilities on Mymetics Corp and Statera Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mymetics Corp with a short position of Statera Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mymetics Corp and Statera Biopharma.

Diversification Opportunities for Mymetics Corp and Statera Biopharma

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Mymetics and Statera is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Mymetics Corp and Statera Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Statera Biopharma and Mymetics Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mymetics Corp are associated (or correlated) with Statera Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Statera Biopharma has no effect on the direction of Mymetics Corp i.e., Mymetics Corp and Statera Biopharma go up and down completely randomly.

Pair Corralation between Mymetics Corp and Statera Biopharma

Given the investment horizon of 90 days Mymetics Corp is expected to generate 3.1 times more return on investment than Statera Biopharma. However, Mymetics Corp is 3.1 times more volatile than Statera Biopharma. It trades about 0.05 of its potential returns per unit of risk. Statera Biopharma is currently generating about -0.16 per unit of risk. If you would invest  2.34  in Mymetics Corp on August 28, 2024 and sell it today you would lose (2.24) from holding Mymetics Corp or give up 95.73% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy4.88%
ValuesDaily Returns

Mymetics Corp  vs.  Statera Biopharma

 Performance 
       Timeline  
Mymetics Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mymetics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Mymetics Corp is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Statera Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Statera Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Statera Biopharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Mymetics Corp and Statera Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mymetics Corp and Statera Biopharma

The main advantage of trading using opposite Mymetics Corp and Statera Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mymetics Corp position performs unexpectedly, Statera Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Statera Biopharma will offset losses from the drop in Statera Biopharma's long position.
The idea behind Mymetics Corp and Statera Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Money Managers
Screen money managers from public funds and ETFs managed around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance